Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Heinz P Schlemmer, MD
German Cancer Research Center
Principal Investigator - James Relle, MD
Corewell Health East
Principal Investigator - Joseph Chin, MD
London Health Science Center
Principal Investigator - Ryan Berglund, MD
The Cleveland Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- London Health Science Centre
London, Ontario, Canada
- German Cancer Research Center (dkfz)
Heidelberg, Germany
- William Beaumont Hospital
Royal Oak, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Mar 2013
- Primary completion
- 23 Mar 2015
- Completion
- 11 Jun 2019
- Last update posted
- 11 Feb 2020
- Registered enrollment
- 30
- Registry id
- NCT01686958
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.